Brief: Medicamen Biotech Forays Into Domestic Pharma Business Via Unit
03/10/2022 12:26
Oct 3 (Reuters) - Medicamen Biotech Ltd MEBI.NS :
* FORAYS INTO DOMESTIC PHARMA BUSINESS VIA UNIT
Source text for Eikon: ID:nBSE7zscPm
Further company coverage: MEBI.NS
((Reutersbriefs@thomsonreuters.com;))
Recent news on Medicamen Biotech
See all newsBrief: Medicamen Biotech Recommends Final Dividend Of 1 Rupee Per Share For FY Ended March 31, 2026
Brief: Medicamen Biotech Gets EU Approval For Registration Of “Paracetamol” From Denmark With XGX Pharma
India's Medicamen Biotech gains on US FDA nod for blood cancer drug
Brief: Medicamen Biotech Approves Allotment Of Shares, Warrants
India's Medicamen Biotech rises after deal with Denmark's XGX Pharma